COVID19-induced immunosuppression and aggressive progression of primary cranial vault lymphoma presenting as a management challenge, a case report, and a literature review.
Vikas Chandra JhaMohammad Shahnawaz AlamPublished in: The Egyptian journal of neurology, psychiatry and neurosurgery (2022)
Early intervention with excisional biopsy and timely chemo and radiotherapy in favorable immunostaining may add survival benefits even in malignant features induced by immunosuppressing diseases such as COVID19 in diffuse large B-cell lymphoma (DLBCL) of the scalp.
Keyphrases
- diffuse large b cell lymphoma
- coronavirus disease
- sars cov
- epstein barr virus
- locally advanced
- randomized controlled trial
- early stage
- high glucose
- photodynamic therapy
- respiratory syndrome coronavirus
- diabetic rats
- ultrasound guided
- squamous cell carcinoma
- drug induced
- free survival
- endothelial cells
- combination therapy
- rectal cancer